Xponance, Inc. Cytokinetics Inc Transaction History
Xponance, Inc.
- $10.7 Billion
- Q4 2024
A detailed history of Xponance, Inc. transactions in Cytokinetics Inc stock. As of the latest transaction made, Xponance, Inc. holds 16,528 shares of CYTK stock, worth $652,525. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,528
Previous 15,675
5.44%
Holding current value
$652,525
Previous $827,000
6.05%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding CYTK
# of Institutions
401Shares Held
115MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$579 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$470 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$424 Million0.31% of portfolio
-
State Street Corp Boston, MA6.17MShares$243 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.84MShares$112 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.72B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...